Disrupting the KRAS-PDEδ interaction disrupts KRAS trafficking and distribution, interfering with the KRAS signaling pathway and effectively inhibiting tumor cell proliferation (Klein et al., 2019; Liu et al., 2019). This evidence concerns the gene KRAS and neoplasm.